CD38 as immunotherapeutic target in light chain amyloidosis and multiple myeloma: association with molecular entities, risk, survival, and mechanisms of upfront resistance - Seckinger, Anja; Hillengaß, Jens; Emde-Rajaratnam, Martina; Beck, Susanne; Kimmich, Christoph; Dittrich, Tobias; Hundemer, Michael; Jauch, Anna; Hegenbart, Ute; Raab, Marc-Steffen; Ho, Anthony Dick; Schönland, Stefan; et al. (Frontiers in immunology, 2018)
Gesehen am 08.08.2018